Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its target price raised by Wedbush from $200.00 to $202.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. Several other equities research analysts have also recently commented on the company. Morgan Stanley boosted […]
Ascendis Pharma A/S (NASDAQ:ASND) Now Covered by Jefferies Financial Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Silverarc Capital Management LLC purchased a new stake in Annexon, Inc. (NASDAQ:ANNX – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 389,911 shares of the company’s stock, valued at approximately $1,372,000. Silverarc Capital Management LLC owned about 0.73% of […]
TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) insider Gregory A. Firestone bought 2,600 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was bought at an average price of $5.65 per share, with a total value of $14,690.00. Following the purchase, the insider now owns 35,511 shares in the […]
EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its price objective hoisted by HC Wainwright from $25.00 to $35.00 in a report issued on Tuesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for EyePoint Pharmaceuticals’ Q4 2023 earnings at ($0.43) EPS, FY2023 earnings at ($1.92) EPS, Q1 […]